GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | May 14, 2025 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
8A64 | 8A64 | cryoEM structure of the catalytically inactive EndoS from S. pyogenes in complex with the Fc region of immunoglobulin G1. | |
8A6C | P02699 | 1 picosecond light activated crystal structure of bovine rhodopsin in Lipidic Cubic Phase | |
8A6D | P02699 | 10 picosecond light activated crystal structure of bovine rhodopsin in Lipidic Cubic Phase | |
8A6E | P02699 | 100 picosecond light activated crystal structure of bovine rhodopsin in Lipidic Cubic Phase (SACLA) | |
8A6L | 8A6L | Human 4F2hc-LAT2 heterodimeric amino acid transporter in complex with anticalin D11vs | |
8A6L | Q9UHI5 | Human 4F2hc-LAT2 heterodimeric amino acid transporter in complex with anticalin D11vs | |
8A7D | Q13219 | Partial dimer complex of PAPP-A and its inhibitor STC2 | |
8A7D | O76061 | Partial dimer complex of PAPP-A and its inhibitor STC2 | |
8A94 | P0DTC2 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A94 | 8A94 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A94 | P0DTC2 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A94 | 8A94 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A95 | P0DTC2 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | 8A95 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | P0DTC2 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | 8A95 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A99 | P0DTC2 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | 8A99 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | P0DTC2 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | 8A99 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A9M | Q7Y041 | Hippeastrum hybrid agglutinin, HHA, complex with beta-mannose | |
8AA0 | Q8A6W3 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
8AA0 | Q8A6W4 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
8AA0 | Q8A6W6 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
8AA0 | Q8A6W5 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
8AA1 | Q8A6W3 | Core SusCD transporter units from the levan utilisome with levan fructo-oligosaccharides DP 8-12 | |
8AA1 | Q8A6W4 | Core SusCD transporter units from the levan utilisome with levan fructo-oligosaccharides DP 8-12 | |
8AA2 | Q8A6W3 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
8AA2 | Q8A6W4 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
8AA2 | Q8A6W6 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
8AA2 | Q8A6W5 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
8AA3 | Q8A6W3 | Core SusCD transporter units from the inactive levan utilisome in the presence of levan fructo-oligosaccharides DP 15-25 | |
8AA3 | Q8A6W4 | Core SusCD transporter units from the inactive levan utilisome in the presence of levan fructo-oligosaccharides DP 15-25 | |
8AB3 | K9Z684 | Crystal Structure of the Lactate Dehydrogenase of Cyanobacterium Aponinum in complex with oxamate, NADH and FBP. | |
8AB6 | Q6CGY9 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6C2E3 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q9B6D0 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6CGP7 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6CI02 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6C3K7 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6C387 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6CG23 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB6 | Q6CC60 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
8AB7 | Q6CGY9 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
8AB7 | Q6C2E3 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
8AB7 | Q9B6D0 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
8AB7 | Q6CGP7 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
8AB7 | Q6CI02 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
8AB7 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025